SEC 13F Intelligence

Blue Chip Partners, LLC / LLY

Blue Chip Partners, LLC’s Eli Lilly & Co Position

Does Blue Chip Partners, LLC own Eli Lilly & Co (LLY)? Yes — 35.4K shares worth $33M (+2.35% of its 13F portfolio) as of Q1 2026, up from 35.2K shares the prior filed quarter.

Position Value
$33M
Q1 2026
Shares
35.4K
% of Portfolio
+2.35%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $284,000Q4 ’18Q1 ’19: $320,000Q2 ’19: $275,000Q3 ’19: $342,000Q4 ’19: $337,000Q4 ’19Q1 ’20: $209,000Q2 ’20: $249,000Q3 ’20: $218,000Q4 ’20: $230,000Q4 ’20Q1 ’21: $255,000Q2 ’21: $314,000Q3 ’21: $337,000Q4 ’21: $404,000Q4 ’21Q1 ’22: $420,000Q2 ’22: $479,000Q3 ’22: $591,000Q4 ’22: $655,199Q4 ’22Q1 ’23: $606,282Q2 ’23: $845,440Q3 ’23: $961,081Q4 ’23: $1MQ4 ’23Q1 ’24: $11MQ2 ’24: $13MQ3 ’24: $14MQ4 ’24: $12MQ4 ’24Q1 ’25: $14MQ2 ’25: $15MQ3 ’25: $18MQ4 ’25: $38MQ4 ’25Q1 ’26: $33Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202635.4K$33M+2.35%
Q4 202535.2K$38M+2.74%
Q3 202523.8K$18M+1.36%
Q2 202519.9K$15M+1.26%
Q1 202517.0K$14M+1.21%
Q4 202415.6K$12M+1.03%
Q3 202415.3K$14M+1.18%
Q2 202414.9K$13M+1.25%
Q1 202413.8K$11M+1.04%
Q4 20231.8K$1M+0.11%
Q3 20231.8K$961,081+0.11%
Q2 20231.8K$845,440+0.10%
Q1 20231.8K$606,282+0.07%
Q4 20221.8K$655,199+0.08%
Q3 20221.8K$591,000+0.08%
Q2 20221.5K$479,000+0.06%
Q1 20221.5K$420,000+0.05%
Q4 20211.5K$404,000+0.05%
Q3 20211.5K$337,000+0.05%
Q2 20211.4K$314,000+0.04%
Q1 20211.4K$255,000+0.04%
Q4 20201.4K$230,000+0.04%
Q3 20201.5K$218,000+0.04%
Q2 20201.5K$249,000+0.05%
Q1 20201.5K$209,000+0.05%
Q4 20192.6K$337,000+0.06%
Q3 20193.1K$342,000+0.07%
Q2 20192.5K$275,000+0.06%
Q1 20192.5K$320,000+0.08%
Q4 20182.5K$284,000+0.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Blue Chip Partners, LLC’s full portfolio or all institutional holders of LLY.